Literature DB >> 2318215

Enterococcal resistance to vancomycin and related cyclic glycopeptide antibiotics.

D M Shlaes1, B Binczewski.   

Abstract

Enterococci belonging to various species resistant to vancomycin and related cyclic glycopeptide antibiotics have been isolated from hospitalized patients in France, the UK and the USA. All such strains examined display inducible synthesis of a membrane protein associated with resistance. The mechanism by which the membrane protein acts has not been definitively established, but it may block the access of the antibiotic to its peptidoglycan target. That the protein could be a bypass enzyme has not been ruled out. Transfer of glycopeptide resistance by conjugation to either Enterococcus faecium or Enterococcus faecalis and by transformation of Streptococcus sanguis Challis has been reported. The structural and regulatory genes encoding this resistance can be localized on plasmid and, apparently, chromosomal DNA. The plasmids encoding this resistance appear to differ from each other and have variable host ranges, but share at least some DNA sequence homology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318215     DOI: 10.1007/bf01963634

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  The effect of defined lipopolysaccharide core defects upon antibiotic resistances of Salmonella typhimurium.

Authors:  R J Roantree; T T Kuo; D G MacPhee
Journal:  J Gen Microbiol       Date:  1977-12

Review 2.  The chemical basis for the action of the vancomycin group of antibiotics.

Authors:  H R Perkins; M Nieto
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

Review 3.  Infective endocarditis in the antibiotic era.

Authors:  P I Lerner; L Weinstein
Journal:  N Engl J Med       Date:  1966-01-27       Impact factor: 91.245

4.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

5.  Carriage of group D streptococci in the human bowel.

Authors:  C J Noble
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

6.  Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis.

Authors:  R C Moellering; O M Korzeniowski; M A Sande; C B Wennersten
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

7.  Inducible resistance to vancomycin in Enterococcus faecium D366.

Authors:  R Williamson; S Al-Obeid; J H Shlaes; F W Goldstein; D M Shlaes
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

8.  Outer membrane of Salmonella typhimurium. Transmembrane diffusion of some hydrophobic substances.

Authors:  H Nikaido
Journal:  Biochim Biophys Acta       Date:  1976-04-16

9.  Enterococcal endocarditis.

Authors:  C J Wilkowske
Journal:  Mayo Clin Proc       Date:  1982-02       Impact factor: 7.616

10.  Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256.

Authors:  D M Shlaes; A Bouvet; C Devine; J H Shlaes; S al-Obeid; R Williamson
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

View more
  9 in total

1.  In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.

Authors:  F Biavasco; R Lupidi; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Increasing resistance of enterococci to ciprofloxacin.

Authors:  D R Schaberg; W I Dillon; M S Terpenning; K A Robinson; S F Bradley; C A Kauffman
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

3.  Antibiotic resistance patterns of enterococci and occurrence of vancomycin-resistant enterococci in raw minced beef and pork in Germany.

Authors:  G Klein; A Pack; G Reuter
Journal:  Appl Environ Microbiol       Date:  1998-05       Impact factor: 4.792

4.  In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms.

Authors:  K V Singh; T M Coque; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

5.  Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients.

Authors:  M Ieven; E Vercauteren; P Descheemaeker; F van Laer; H Goossens
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

6.  Increasing problems in the therapy of enterococcal infections.

Authors:  G M Eliopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

7.  Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients.

Authors:  B Gordts; H Van Landuyt; M Ieven; P Vandamme; H Goossens
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

8.  Characterization of glycopeptide-resistant enterococci from U.S. hospitals.

Authors:  N C Clark; R C Cooksey; B C Hill; J M Swenson; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

9.  In vitro activities of ramoplanin and four glycopeptide antibiotics against clinical isolates of Clostridium difficile.

Authors:  F Biavasco; E Manso; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.